Population-based variation in cardiomyopathy genes

Circulation: Cardiovascular Genetics

Volumn 5, Issue 4, 2012, Pages 391-399

  Golbus, Jessica R ^a   Puckelwartz, Megan J ^a   Fahrenbach, John P ^a   Dellefave Castillo, Lisa M ^a   Wolfgeher, Don ^a   McNally, Elizabeth M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cardiomyopathy; Hypertrophic cardiomyopathy; Myosin heavy chain; Myosin binding subunit; Titin

Indexed keywords

CONNECTIN; DNA; MYOSIN HEAVY CHAIN;

ARTICLE; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; DNA SEQUENCE; ETHNIC GROUP; EXON; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC DATABASE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN GENOME PROJECT; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SUBUNIT; SARCOMERE; SINGLE NUCLEOTIDE POLYMORPHISM;

CARDIAC MYOSINS; CARDIOMYOPATHIES; CARRIER PROTEINS; CONTINENTAL POPULATION GROUPS; DATABASES, GENETIC; FRAMESHIFT MUTATION; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENETICS, POPULATION; GENOME, HUMAN; HUMANS; MUSCLE PROTEINS; MUTATION, MISSENSE; MYOSIN HEAVY CHAINS; OPEN READING FRAMES; PROTEIN KINASES; SARCOMERES;

EID: 84867824466     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.112.962928     Document Type: Article

References (29)

1. Watkins H, Ashrafian H, Redwood C. Inherited cardiomyopathies. N Engl J Med. 2011;364:1643-1656.
2. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785-789.
3. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopa-thy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:e783-e831.
4. Otsuka H, Arimura T, Abe T, Kawai H, Aizawa Y, Kubo T, Kitaoka H, Nakamura H, Nakamura K, Okamoto H, Ichida F, Ayusawa M, Nunoda S, Isobe M, Matsuzaki M, Doi YL, Fukuda K, Sasaoka T, Izumi T, Ashizawa N, Kimura A. Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy. Circ J. 2012;76:453-461.
5. Xu Q, Dewey S, Nguyen S, Gomes AV. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes. J Mol Cell Cardiol. 2010;48:899-909.
6. Petretta M, Pirozzi F, Sasso L, Paglia A, Bonaduce D. Review and metaanalysis of the frequency of familial dilated cardiomyopathy. Am J Cardiol. 2011;108:1171-1176.
7. Millat G, Bouvagnet P, Chevalier P, Sebbag L, Dulac A, Dauphin C, Jouk PS, Delrue MA, Thambo JB, Le Metayer P, Seronde MF, Faivre L, Eicher JC, Rousson R. Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy. Eur J Med Genet. 2011;54:e570-e575.
8. Gerull B, Gramlich M, Atherton J, McNabb M, Trombitas K, Sasse-Klaassen S, Seidman JG, Seidman C, Granzier H, Labeit S, Frenneaux M, Thierfibroer L. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet. 2002;30:201-204.
9. Gerull B, Atherton J, Geupel A, Sasse-Klaassen S, Heuser A, Frenneaux M, McNabb M, Granzier H, Labeit S, Thierfibroer L. Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy. J Mol Med (Berl). 2006;84:478-483. (Pubitemid 43801326)
10. Taylor M, Graw S, Sinagra G, Barnes C, Slavov D, Brun F, Pinamonti B, Salcedo EE, Sauer W, Pyxaras S, Anderson B, Simon B, Bogomolovas J, Labeit S, Granzier H, Mestroni L. Genetic variation in titin in arrhythmo-genic right ventricular cardiomyopathy-overlap syndromes. Circulation. 2011;124:876-885.
11. Linke WA. Sense and stretchability: the role of titin and titin-associat-ed proteins in myocardial stress-sensing and mechanical dysfiunction. Cardiovasc Res. 2008;77:637-648. (Pubitemid 351301882)
12. 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061-1073.
13. International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299-1320.
14. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11:863-874. (Pubitemid 32447869)
15. Gonzalez-Perez A, Lopez-Bigas N. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet. 2011;88:440-449.
16. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248-249.
17. Le Winter MM, Granzier H. Cardiac titin: a multifunctional giant. Circulation. 2010;121:2137-2145.
18. Ewing B, Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 1998;8:186-194. (Pubitemid 28177230)
19. Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 1998;8:175-185. (Pubitemid 28177229)
20. Blair E, Redwood C, De Jesus Oliveira M, Moolman-Smook JC, Brink P, Corfibro VA, Ostman-Smith I, Watkins H. Mutations of the light mero-myosin domain of the beta-myosin heavy chain rod in hypertrophic car-diomyopathy. Circ Res. 2002;90:263-269. (Pubitemid 34633926)
21. Buvoli M, Hamady M, Leinwand LA, Knight R. Bioinformatics assessment of beta-myosin mutations reveals myosin's high sensitivity to mutations. Trends Cardiovasc Med. 2008;18:141-149. (Pubitemid 351794543)
22. Miller MK, Granzier H, Ehler E, Gregorio CC. The sensitive giant: the role of titin-based stretch sensing complexes in the heart. Trends Cell Biol. 2004;14:119-126. (Pubitemid 38293454)
23. Freeman K, Nakao K, Leinwand LA. Low sequence variation in the gene encoding the human beta-myosin heavy chain. Genomics. 2001;76:73-80. (Pubitemid 32744626)
24. Dellefave L, McNally EM. The genetics of dilated cardiomyopathy. Curr Opin Cardiol. 2010;25:198-204.
25. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, McGee S, Do R, Liu X, Jun. G, Kang HM, Jordan D, Leal SM, Gabriel S, Rieder MJ, Abecasis G, Altshuler D, Nickerson DA, Boerwinkle E, Sunyaev S, Bustamante CD, Bamshad MJ, Akey JM; Broad GO; Seattle GO; NHLBI Exome Sequencing Project. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science. 2012;337:64-69.
26. Hamady M, Buvoli M, Leinwand LA, Knight R. Estimate of the abundance of cardiomyopathic mutations in the beta-myosin gene. Int J Cardiol. 2010;144:124-126.
27. Ingles J, Doolan A, Chiu C, Seidman J, Seidman C, Semsarian C. Compound and double mutations in patients with hypertrophic cardio-myopathy: implications for genetic testing and counselling. J Med Genet. 2005;42:e59.
28. Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, Conner L, De Palma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitchell RN, Murry CE, Lakdawala NK, Ho CY, Barton PJ, Cook SA, Mestroni L, Seidman JG, Seidman CE. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012;366:619-628.
29. Clark MJ, Chen R, Lam HY, Karczewski KJ, Euskirchen G, Butte AJ, Snyder M. Performance comparison of exome DNA sequencing technologies. Nat Biotechnol. 2011;29:908-914.